Edited by
JUDITH E. KARP

2007

Acute myelogenous leukemia (AML) is a complex family of malignancies for which we need new treatment concepts and agents in order to increase the cure rates for all who suffer with these diseases. On the clinical level, AML is an important and devastating malignancy that affects all ages.